23. Dicaffeoyltartaric Acid and Dicaffeoylquinic Acid HIV Integrase Inhibitors
- Nouri Neamati
Published Online: 28 SEP 2011
DOI: 10.1002/9781118015377.ch23
Copyright © 2011 John Wiley & Sons, Inc.
Book Title
HIV-1 Integrase: Mechanism and Inhibitor Design
Additional Information
How to Cite
Crosby, D. C. and Robinson, W. E. (2011) Dicaffeoyltartaric Acid and Dicaffeoylquinic Acid HIV Integrase Inhibitors, in HIV-1 Integrase: Mechanism and Inhibitor Design (ed N. Neamati), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118015377.ch23
Editor Information
Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, School of Pharmacy, Los Angeles, California, USA
Publication History
- Published Online: 28 SEP 2011
- Published Print: 9 SEP 2011
ISBN Information
Print ISBN: 9780470184745
Online ISBN: 9781118015377
- Summary
- Chapter
- References
Keywords:
- dicaffeoyltartaric acid, and HIV IN inhibitors;
- L-CA, antiviral and anti-IN activity;
- L-CA, partner antiretroviral therapy
Summary
This chapter contains sections titled:
Introduction
Discovery
Characterization of L-CA as a Selective IN Inhibitor
Controversy Surrounding In Vivo Site of Action For L-CA
Mechanisms of Viral Resistance
Stucture-Activity Relationship Studies
L-CA in Combination with Reverse Transcriptase and Protease Inhibitors
Summary
Acknowledgments
References